MSH2 and cancer: The finding of two independent LS-causing variants within these two different MMR genes in one branch of Family C has strong implications for cancer risk stratification given the overall higher risks for cancer in carriers of pathogenic variants of MSH2 than MSH6, clinical surveillance, and genetic counseling for their respective risks of cancer and inheritance.